Published in Transl Androl Urol on October 01, 2016
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol (2013) 4.58
Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer (2009) 3.10
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology (2011) 2.76
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol (2006) 2.51
Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol (2013) 2.26
Women and tobacco: a call for including gender in tobacco control research, policy and practice. Tob Control (2011) 2.24
Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol (2015) 2.24
Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors. J Urol (2012) 2.14
Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials. Eur Urol (2007) 1.98
Delays in diagnosis and bladder cancer mortality. Cancer (2010) 1.92
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol (2009) 1.65
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int (2013) 1.64
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol (2010) 1.61
Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer (2013) 1.60
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology (2014) 1.58
Gender differences in stage-adjusted bladder cancer survival. Urology (2000) 1.55
Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer (2006) 1.54
Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis. JAMA Oncol (2015) 1.51
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int (2012) 1.46
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. J Urol (2012) 1.43
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. Urol Oncol (2014) 1.43
Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol (2004) 1.41
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis (2007) 1.40
The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int (2009) 1.38
Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol (2005) 1.35
Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol (2003) 1.29
The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer (2009) 1.29
Gender differences in stage distribution of bladder cancer. Urology (2000) 1.25
Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology (2004) 1.23
Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol (2011) 1.21
Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer (2006) 1.09
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog (2011) 1.07
Androgen activates β-catenin signaling in bladder cancer cells. Endocr Relat Cancer (2013) 1.06
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer (2008) 1.06
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol (2010) 1.06
Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res (2007) 1.04
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol (2011) 1.01
Patterns of care for the treatment of bladder cancer. J Urol (2003) 1.00
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. J Natl Cancer Inst (2013) 1.00
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries. J Gen Intern Med (2014) 0.96
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol (2012) 0.96
Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol (2013) 0.95
Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity. World J Urol (2013) 0.94
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol (2012) 0.94
Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review. J Infect Chemother (2014) 0.94
Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol (2013) 0.93
Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol (2009) 0.93
Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol (2003) 0.93
Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol (2014) 0.92
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol (2015) 0.92
Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol (2006) 0.91
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol (2012) 0.90
Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals. PLoS One (2014) 0.89
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol (2011) 0.88
Hair dye use and risk of bladder cancer in the New England bladder cancer study. Int J Cancer (2011) 0.88
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol (2015) 0.88
Bladder cancer and urinary Schistosomiasis in Angola. J Nephrol Res (2015) 0.87
Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem (1981) 0.87
Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol (2014) 0.87
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int (2010) 0.86
Gender-dependent cancer-specific survival following radical cystectomy. World J Urol (2011) 0.86
Gonorrhoea and male bladder cancer in a prospective study. Br J Cancer (2006) 0.85
Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol (2010) 0.85
Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer (2013) 0.84
The impact of gender on outcomes in patients with metastatic urothelial carcinoma. Clin Genitourin Cancer (2013) 0.83
Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol (2014) 0.83
Sex disparities in cancer mortality: the risks of being a man in the United States. J Urol (2012) 0.83
Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries. Urol Oncol (2013) 0.82
The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer (2015) 0.82
Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer. Curr Opin Urol (2014) 0.81
Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study. Urology (1997) 0.81
Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. Int Urol Nephrol (2008) 0.81
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Transl Oncol (2013) 0.81
Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2013) 0.80
Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol (2013) 0.80
Chemotherapy-induced bladder cancer. Scand J Urol Nephrol Suppl (2008) 0.80
Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy. Urol Oncol (2013) 0.80
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int (2015) 0.79
The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU Int (2009) 0.79
Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer. Curr Urol Rep (2014) 0.79
Cystectomy in women. BJU Int (2008) 0.79
Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol (2013) 0.78
Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort. Eur J Surg Oncol (2014) 0.78
Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia. Cancer Med (2015) 0.78
Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int (2011) 0.77
The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis. World J Surg Oncol (2014) 0.77
Conditional Survival in de novo Metastatic Urothelial Carcinoma. PLoS One (2015) 0.77
[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies]. Urologe A (2012) 0.77
Is there a gender effect in bladder cancer? A population-based study of practice and outcomes. Can Urol Assoc J (2015) 0.77
Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder. Eur Urol (2013) 0.76
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study. Can Urol Assoc J (2014) 0.76
Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis. Clin Genitourin Cancer (2015) 0.76
Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study. Urol Int (2014) 0.76
A protocol based, electronic medical record enabled care coordination system improves the timeliness and efficiency of care for patients with hematuria. J Urol (2013) 0.75
A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy. J Urol (2014) 2.76
Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol (2015) 2.76
Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes. BJU Int (2015) 1.40
Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer. Int J Urol (2016) 1.39
Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol (2013) 0.95
Outcomes of Ventral Onlay Buccal Mucosa Graft Urethroplasty in Patients after Radiotherapy. J Urol (2015) 0.88
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract. J Urol (2014) 0.87
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer. Int J Cancer (2015) 0.87
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World J Urol (2016) 0.85
The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Urology (2015) 0.84
Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis. BMJ Open (2016) 0.82
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2013) 0.82
The impact of resident involvement in male one-stage anterior urethroplasties. Urology (2015) 0.82
An evaluation of the 'weekend effect' in patients admitted with metastatic prostate cancer. BJU Int (2015) 0.81
Causes of hospital readmissions after urologic cancer surgery. Urol Oncol (2015) 0.81
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int (2015) 0.79
Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma. Urol Oncol (2014) 0.79
Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy. Urol Oncol (2014) 0.79
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. Urol Oncol (2016) 0.78
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol (2016) 0.78
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol (2014) 0.78
Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. World J Urol (2017) 0.78
Redo buccal mucosa graft urethroplasty: success rate, oral morbidity and functional outcomes. BJU Int (2016) 0.77
Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study. BJU Int (2016) 0.77
Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer (2014) 0.77
Reduced membranous MET expression is linked to bladder cancer progression. Cancer Genet (2014) 0.77
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study. Urol Oncol (2015) 0.77
Direct Vision Internal Urethrotomy for Short Anterior Urethral Strictures and Beyond: Success Rates, Predictors of Treatment Failure and Recurrence Management. Urology (2017) 0.77
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. World J Urol (2016) 0.76
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol (2015) 0.76
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients. Prostate (2016) 0.76
Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU Int (2015) 0.76
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World J Urol (2016) 0.75
Inpatients hypospadias care: trends and outcomes from the American nationwide inpatient sample. Korean J Urol (2015) 0.75
Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses? Transl Androl Urol (2016) 0.75
Differences in Recurrence Rate and De Novo Incontinence after Endoscopic Treatment of Vesicourethral Stenosis and Bladder Neck Stenosis. Front Surg (2017) 0.75
Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder. Urol Oncol (2016) 0.75
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma. World J Urol (2014) 0.75
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. Urol Oncol (2017) 0.75
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? Urol Oncol (2022) 0.75
Editorial Comment. J Urol (2016) 0.75
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High-Grade Upper Tract Urothelial Carcinoma. J Urol (2017) 0.75
A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy. Int J Cancer (2016) 0.75
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol (2017) 0.75
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. World J Urol (2015) 0.75
Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. Oncotarget (2017) 0.75
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort. Clin Genitourin Cancer (2017) 0.75
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer. World J Urol (2019) 0.75
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Urol Oncol (2016) 0.75
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer. Prostate (2017) 0.75
Outcomes of single- vs double-cuff artificial urinary sphincter insertion in low- and high-risk profile male patients with severe stress urinary incontinence. BJU Int (2016) 0.75
Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity. Eur Urol (2017) 0.75
Local Therapy Improves Survival in Metastatic Prostate Cancer. Eur Urol (2017) 0.75
Urethral Stricture Formation Following Cuff Erosion of AMS Artificial Urinary Sphincter Devices: Implication for a Less Invasive Explantation Approach. Front Surg (2022) 0.75
Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer (2017) 0.75
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. Eur Urol Focus (2015) 0.75
Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. Oncotarget (2017) 0.75
Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis. Aging Male (2022) 0.75
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Eur Urol Focus (2016) 0.75
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. World J Urol (2016) 0.75
Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey. Eur Urol Focus (2017) 0.75
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. Urol Oncol (2020) 0.75
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer (2015) 0.75
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer. World J Urol (2022) 0.75
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration. World J Urol (2022) 0.75
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World J Urol (2016) 0.75
Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol Oncol (2016) 0.75
Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy. BJU Int (2017) 0.75
Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events. BJU Int (2015) 0.75
Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes. Eur Urol Focus (2015) 0.75